💥Fed cuts sparks mid cap boom! ProPicks AI scores with 4 stocks +23% each. Get October’s update first.Pick Stocks with AI

Recce Pharmaceuticals appoints Alistair McKeough as non-executive director

Published 01/09/2022, 03:21 pm
Updated 01/09/2022, 03:30 pm
© Reuters.  Recce Pharmaceuticals appoints Alistair McKeough as non-executive director

Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) has appointed Alistair McKeough as non-executive director and Maggie Niewidok as company secretary, effective today.

McKeough is a solicitor with extensive operational and board experience in many sectors, including professional services, technology, biotechnology, financial services, education and charities.

“He knows the company well”

Recce chairman Dr John Prendergast said: “Strengthening the corporate governance of the Board has been an area of key focus of mine as the company’s infectious disease programs move ahead and become institutionally relevant, locally and overseas.

“The Board and I are delighted to welcome Alistair as a non-executive director.

“He knows the company well, is excited about the future for Recce and brings deep insights into Australia’s financial, corporate and regulatory environments.”

Extensive experience

McKeough was formerly Head of Professional Services at Automic Group, which acquired his legal, company secretarial and corporate governance business, Whittens & McKeough, in 2018.

He is currently the chair of the Waratah Education Foundation.

McKeough has had deep leadership experience in many high-performing companies, in which he has had responsibility for a range of organisational performance outcomes including safety and risk management, corporate governance, legal compliance, cost reduction, strategy, change management, M&A, capital raising, culture and value creation.

McKeough has immediately stepped out of the company secretary role to become a director of Recce, having served as Recce’s company secretary and primary legal adviser from 29 November 2017 to 31 August 2022.

He will also assume the role of chair of the company’s audit and risk management committee.

New company secretary

Maggie Niewidok has taken on the role of company secretary.

Maggie is an experienced solicitor and company secretary who has worked across a broad industry base of ASX-listed companies.

Prendergast added: “I’m also delighted to welcome Maggie as Company Secretary.

“She has worked with the company for much of this year, and is extremely capable.

“On behalf of the Board and shareholders, I welcome Alistair and Maggie and look forward to their contributions.”

Read more on Proactive Investors AU

Disclaimer

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.